×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARDX – ardelyx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARDX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/11
02:45 pm
ardx
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop [Seeking Alpha]
Low
Report
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop [Seeking Alpha]
11/11
07:32 am
ardx
Ardelyx, Inc. (NASDAQ: ARDX) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $5.50 price target on the stock, down previously from $11.00.
Low
Report
Ardelyx, Inc. (NASDAQ: ARDX) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $5.50 price target on the stock, down previously from $11.00.
11/8
12:49 pm
ardx
Ardelyx Responds to District Court Decision Granting Motion to Dismiss [Yahoo! Finance]
Low
Report
Ardelyx Responds to District Court Decision Granting Motion to Dismiss [Yahoo! Finance]
11/8
12:31 pm
ardx
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Low
Report
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
11/5
08:00 am
ardx
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
Medium
Report
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
11/4
12:44 pm
ardx
Ardelyx, Inc. (NASDAQ: ARDX) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Ardelyx, Inc. (NASDAQ: ARDX) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $10.00. They now have a "buy" rating on the stock.
11/1
04:19 pm
ardx
Ardelyx, Inc. (NASDAQ: ARDX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Low
Report
Ardelyx, Inc. (NASDAQ: ARDX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
10/31
08:35 pm
ardx
Ardelyx: Q3 Earnings Snapshot [Yahoo! Finance]
Low
Report
Ardelyx: Q3 Earnings Snapshot [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:27 pm
ardx
Form 4 ARDELYX, INC. For: Nov 13 Filed by: MOTT DAVID M
Low
Report
Form 4 ARDELYX, INC. For: Nov 13 Filed by: MOTT DAVID M
11/14
04:10 pm
ardx
Form SC 13G/A ARDELYX, INC. Filed by: JANUS HENDERSON GROUP PLC
Medium
Report
Form SC 13G/A ARDELYX, INC. Filed by: JANUS HENDERSON GROUP PLC
11/12
05:01 pm
ardx
Form 4 ARDELYX, INC. For: Nov 11 Filed by: RAAB MICHAEL
Low
Report
Form 4 ARDELYX, INC. For: Nov 11 Filed by: RAAB MICHAEL
11/12
11:45 am
ardx
Form 144 ARDELYX, INC. Filed by: RAAB MICHAEL
Low
Report
Form 144 ARDELYX, INC. Filed by: RAAB MICHAEL
11/8
06:01 pm
ardx
Form 4 ARDELYX, INC. For: Nov 06 Filed by: Rosenbaum David P.
Medium
Report
Form 4 ARDELYX, INC. For: Nov 06 Filed by: Rosenbaum David P.
11/6
06:00 pm
ardx
Form 4 ARDELYX, INC. For: Nov 04 Filed by: Rosenbaum David P.
Low
Report
Form 4 ARDELYX, INC. For: Nov 04 Filed by: Rosenbaum David P.
10/31
04:08 pm
ardx
Form 10-Q ARDELYX, INC. For: Sep 30
Medium
Report
Form 10-Q ARDELYX, INC. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
9/2
Ardelyx to Host Conference Call on September 3 to Review Results from the Pivotal Phase 3 AMPLIFY Study
71.2%
11/25 Ardelyx and Kyowa Kirin Expand Partnership with Two Additional Agreements 18.2%
12/3 UPDATE 1-Ardelyx's kidney disease drug reduces elevated phosphate levels in late-stage study [Yahoo! Finance News] 16.8%
3/16 Form 4 ARDELYX, INC. For: Mar 12 Filed by: Cadoret-Manier Onaiza 13.9%
9/6 Ardelyx Inc (NASDAQ: ARDX) was given a new $15.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock. 13.3%
12/4 Ardelyx launches $80M stock offering; shares down 1% after hours [Seeking Alpha] 11.5%
2/14 Form SC 13G ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P. 10.6%
9/12 Ardelyx Receives FDA Approval for IBSRELA® (Tenapanor), an NHE3 Sodium Transport Inhibitor, for the Treatment of Irritable Bowel Syndrome with Constipation 9.2%
10/10 Ardelyx to Host Analyst Day in New York 8.9%
8/20 Form 4 ARDELYX, INC. For: Aug 19 Filed by: GRAMMER ELIZABETH A 8.9%
11/25 Ardelyx and Kyowa Kirin Expand Partnership with Two Additional Agreements 18.2%
12/3 UPDATE 1-Ardelyx's kidney disease drug reduces elevated phosphate levels in late-stage study [Yahoo! Finance News] 16.8%
3/16 Form 4 ARDELYX, INC. For: Mar 12 Filed by: Cadoret-Manier Onaiza 13.9%
9/6 Ardelyx Inc (NASDAQ: ARDX) was given a new $15.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock. 13.3%
12/4 Ardelyx launches $80M stock offering; shares down 1% after hours [Seeking Alpha] 11.5%
2/14 Form SC 13G ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P. 10.6%
9/12 Ardelyx Receives FDA Approval for IBSRELA® (Tenapanor), an NHE3 Sodium Transport Inhibitor, for the Treatment of Irritable Bowel Syndrome with Constipation 9.2%
10/10 Ardelyx to Host Analyst Day in New York 8.9%
8/20 Form 4 ARDELYX, INC. For: Aug 19 Filed by: GRAMMER ELIZABETH A 8.9%
TOP News Decliners
12/3
Form 8-K ARDELYX, INC. For: Dec 03
-15.8%
3/16 Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors -13.0%
2/20 Form 5 ARDELYX, INC. For: Sep 05 Filed by: Rosenbaum David P. -9.0%
3/17 Form 8-K ARDELYX, INC. For: Mar 12 -8.4%
2/24 Ardelyx Inc (NASDAQ: ARDX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -8.3%
1/24 Double Your Money with This Biotech [The Motley Fool] -7.9%
9/16 Ardelyx Inc (NASDAQ: ARDX) was given a new $15.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock. -7.7%
2/13 Ardelyx Inc (NASDAQ: ARDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -6.8%
10/8 Form 4 ARDELYX, INC. For: Oct 07 Filed by: Kaufmann Mark -6.4%
6/14 Form 8-K ARDELYX, INC. For: Jun 13 -6.4%
3/16 Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors -13.0%
2/20 Form 5 ARDELYX, INC. For: Sep 05 Filed by: Rosenbaum David P. -9.0%
3/17 Form 8-K ARDELYX, INC. For: Mar 12 -8.4%
2/24 Ardelyx Inc (NASDAQ: ARDX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -8.3%
1/24 Double Your Money with This Biotech [The Motley Fool] -7.9%
9/16 Ardelyx Inc (NASDAQ: ARDX) was given a new $15.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock. -7.7%
2/13 Ardelyx Inc (NASDAQ: ARDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -6.8%
10/8 Form 4 ARDELYX, INC. For: Oct 07 Filed by: Kaufmann Mark -6.4%
6/14 Form 8-K ARDELYX, INC. For: Jun 13 -6.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: